SIGN UP
LOG IN
1
ATNF
180 Life Sciences Corp
0.83
-0.04-4.27%After Hours: 0.8646 +0.0346 +4.17%17:09 06/27 EDT
OPEN/PREV CLOSE0.8501/0.8670
TODAY RANGE0.8200-0.8501
VOL26.48K
MARKET CAP4.62M
52 WEEK RANGE0.6578-17.75
AVG VOL (3M)135.77K
% TURNOVER0.48%
TURNOVER--
P/E (TTM)-0.0666
% RANGE3.47%
EPS(TTM)-12.4599
P/E(FORWARD)-0.0047
P/B0.5586
BVPS1.486
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.73M
SHARES OUTSTANDING5.57M
NEXT EARNINGS08/11-08/15
FREE FLOAT3.29M
LOT SIZE1
EX-DATE02/28/2024
News
Press Releases
Financial Reports
Profile
TipRanks·3d ago
180 Life Sciences Schedules 2025 Annual Shareholder Meeting
TipRanks·06/20 21:21
180 Life Sciences Grants Stock Options to Executives
Seeking Alpha·06/20 20:26
180 Life Sciences announces $500M mixed shelf offering
Benzinga·06/20 20:20
180 Life Sciences Files For Mixed Shelf Of Up To $500M
Reuters·06/20 20:17
180 LIFE SCIENCES CORP FILES FOR MIXED SHELF OF UP TO $500 MLN – SEC FILING
TipRanks·06/18 21:58
180 Life Sciences Adopts 2025 Option Incentive Plan
Seeking Alpha·05/20 14:46
Psychedelic stocks rise as FDA chief’s comments seen favorable to industry
Press release·05/15 21:32
180 LIFE SCIENCES CORP. AND SUBSIDIARIES FORM 10-Q FOR THE THREE MONTHS ENDED MARCH 31, 2025
TipRanks·05/09 20:26
180 Life Sciences files to sell 753K shares of common stock for holders
Benzinga·05/06 21:06
12 Health Care Stocks Moving In Tuesday's After-Market Session
TipRanks·05/01 13:41
180 Life Sciences announces notice of allowance for U.S. patent
TipRanks·04/30 13:31
180 Life Sciences enters settlement, mutual release agreement with Elray, Luxor
TipRanks·04/30 13:08
180 Life Sciences Settles Disputes with Elray Resources
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.